Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05608109 · ClinicalTrials.gov registry record · NA
A Social Media Personalized Normative Feedback Intervention for Heavy Drinking College Students
A NA study, sponsored by Duquesne University.
- Completed
- Registry status
- NA
- Development phase
- 401
- Enrollment target
NCT05608109: Completed NA study, sponsored by Duquesne University.
NCT05608109 is a NA study that has completed, run by Duquesne University. The registered enrollment target is 401 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05608109, a NA study, has completed, sponsored by Duquesne University.
- COMPLETED
- Registry status
- NA
- Development phase
- 401 participants
- Enrollment target
Study Summary
This study seeks to evaluate the unique and synergistic efficacy of social media-specific personalized normative feedback targeting the reduction of alcohol use among heavy-drinking college students who post alcohol-related content on social media. Hypothesis: Alcohol personalized normative feedback, social media-specific personalized normative feedback, and the Alcohol personalized normative feedback+ social media-specific personalized normative feedback conditions will be more effective in reducing drinking than the attention control condition.
Primary Outcome
The B-YAACQ is a 24 item assessment which measures consequences in 8 domains over a given time frame. Subscales include: Social/Interpersonal, Academic/Occupational, Risky Behavior, Impaired Control, Poor Self-Care, Diminished Self-Perception, Blackout Drinking, and Physiological Dependence. Minimum value: 0; Maximum Value: 24; Higher scores indicate more alcohol-related problems.
Interventions
- BEHAVIORAL Alcohol personalized normative feedback (APNF)
- BEHAVIORAL Social media personalized normative feedback (SMPNF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2022-01-09 |
| Est. Completion | 2024-12-28 |
| Phase | NA |
What the finished NCT05608109 record still lists
NCT05608109 is an interventional study that assigns participants to a tested intervention. The registered 401 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 2 interventions - of which Alcohol personalized normative feedback (APNF) is the first listed.
NCT05608109 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05608109 about?
NCT05608109 is a clinical study titled "A Social Media Personalized Normative Feedback Intervention for Heavy Drinking College Students". This study seeks to evaluate the unique and synergistic efficacy of social media-specific personalized normative feedback targeting the reduction of alcohol use among heavy-drinking college students who post alcohol-related content on social media. Hypothesis: Alcohol personalized normative feedbac...
What is the current status of trial NCT05608109?
This trial is currently completed. It is a NA study. The enrollment target is 401 participants. The study started on 2022-01-09. Estimated completion is 2024-12-28.
What interventions are being tested in trial NCT05608109?
The interventions under investigation include: Alcohol personalized normative feedback (APNF) (BEHAVIORAL), Social media personalized normative feedback (SMPNF) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05608109?
This trial is sponsored by Duquesne University, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05608109's enrollment target sits among peer trials
401 246th of 2000 higher than 1,755 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI